The intro pricing on OrderlyMeds' tirzepatide is aggressive and the standard pricing is not, so the important question is which one you will actually be paying in month three.
Compounded tirzepatide runs $299 a month standard, with a new-customer starter of $299 for two months — an effective $149 a month — at the lowest dose, paid upfront. A returning-member offer is advertised at an equivalent $224 a month.
The standard $299 is the highest compounded tirzepatide medication price in our set, above Measured's $219 and Eden's $199. Against all-in figures it sits behind CoreAge Rx at $129 and Mochi at $169 by a wide margin.
What justifies the premium
Disclosure, essentially. Named 503A pharmacies sourcing the base molecule rather than salt forms — a direct response to the FDA warning about semaglutide and tirzepatide salt forms — with USP-standard sterility and potency batch testing. Published BMI thresholds and exclusions. A stated requirement that the compounded preparation produce a significant difference versus the approved product.
Prices also do not rise with dose, which matters for tirzepatide's stepwise titration. The catch is the commitment structure rather than the dose structure: the intro rate needs two months paid upfront at 2.5 mg, and once the prescription is finalised you cannot cancel.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What compounded tirzepatide actually is
Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.
Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.
Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.
Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.